ARCHIVES

Velcade Improves Survival In Relapsed Multiple Myeloma

This article is from The Cancer Letter archive.

Vol. 28 No. 7 | July 29, 2005

Download PDF Visit The Full Archive

Related Articles

Vidaza For MDS Approved; sNDAs for Taxotere, Gemzar

May 28, 2004

Caris Life Sciences Lays Off Estimated 20 Percent of Staff

October 24, 2014

Cancer center directors to develop blueprint for progress that’s “honest,” M.D. Anderson’s John Mendelsohn says.

November 23, 2005

Advisors Suggest Consortia For Lung Cancer Research.

November 9, 2001

Breast Cancer Action Plan Committee Outrages By Plans for $14M In NCI Funds

August 1, 1997

Breast Cancer Death Rates Improving, NCI Says

May 10, 1996